Ƶ

Morning Break: The B.O. Talk, No Love for Niacin

— Health news and commentary from around the Web, gathered by the Ƶ staff.

Ƶ MedicalToday
image

How do you bring up bad body odor with coworkers? (Of course, .)

There's . The HPS2-THRIVE trial, reported in the New England Journal of Medicine, found that the combination of niacin and laropiprant (Tedaptive) didn't reduce major cardiovascular events but carried a greater risk of serious adverse events. Check back for Ƶ special coverage on Friday.

The feds weren't stashing only smallpox. The FDA's search of a storeroom turned up tubes of along with those six forgotten smallpox samples, according to USA Today. CDC director Thomas Frieden, MD, MPH, about safety lapses at that agency.

Will the make it to market sooner than expected?

Nephrologists at Renal Fellow Network warn about

The number of people living with HIV remained unchanged -- at 35 million -- in 2012 and 2013, according to .

A New York Times Magazine essayist reminisces about her mother's .

The largest ever study on the effects of the main psychoactive component of cannabis suggests that compared with nonusers (though, as often happens, correlation was interpreted as causation).

It's not easy to assess a doctor's true skills, according to .

Quality control measures proposed by the Centers for Medicaid and Medicare Services (CMS) for 2015 of having colonoscopy.

A grieving father reached out to the Reddit community for help in Photoshopping the tubes on his terminally ill 6-week-old daughter, who never got to leave the hospital. Several users .

United Health, the big insurer, reported that its in the most recent quarter over a year earlier and a surge in revenues as well -- citing the Affordable Care Act among other factors as the reason.

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the Ƶ community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.